Literature DB >> 18266208

Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong.

Geoffrey T Gibney1, Carolien I M Panhuysen, Jason C C So, Edmond S K Ma, Shau Yin Ha, Chi Kong Li, Anselm C W Lee, Chi Keung Li, Hui Leung Yuen, Yu Lung Lau, David M Johnson, John J Farrell, Alice B Bisbee, Lindsay A Farrer, Martin H Steinberg, Li Chong Chan, David H K Chui.   

Abstract

Enhanced fetal hemoglobin (Hb F) production can partially compensate for the lack of adult hemoglobin (Hb A) in patients with beta-thalassemia major or intermedia, and ameliorate the clinical severity of these diseases. To further elucidate factors governing Hb F levels, we evaluated demographic, clinical, laboratory, and genetic characteristics in 241 unrelated adult beta-thalassemia carriers in Hong Kong. They had wide variations in Hb F and F-cell numbers skewing toward higher levels. Individuals who coinherited the Xmn IT-allele in the (G)gamma-globin gene promoter had higher Hb F and more F-cells compared with those lacking the Xmn I T-allele. However, both groups exhibited a similarly wide spread of Hb F and F-cells. The correlation of Hb F and F-cells corresponded well to both linear and exponential models, suggesting multiple mechanisms for Hb F augmentation. The heritabilities of Hb F and F-cells were calculated in 66 families (111 parents who were beta-thalassemia carriers and 82 asymptomatic offspring) to be 0.7 to 0.9. The Xmn I polymorphism accounted for 9% of the Hb F and 13% of the F-cell heritabilities. These results suggest that these family members are well suited for genome wide association studies that will identify genetic loci regulating Hb F production, and likely novel pharmacological targets for reactivating Hb F production in adults. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266208     DOI: 10.1002/ajh.21150

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.

Authors:  Nadia Solovieff; Jacqueline N Milton; Stephen W Hartley; Richard Sherva; Paola Sebastiani; Daniel A Dworkis; Elizabeth S Klings; Lindsay A Farrer; Melanie E Garrett; Allison Ashley-Koch; Marilyn J Telen; Supan Fucharoen; Shau Yin Ha; Chi-Kong Li; David H K Chui; Clinton T Baldwin; Martin H Steinberg
Journal:  Blood       Date:  2009-12-16       Impact factor: 22.113

4.  A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.

Authors:  John J Farrell; Richard M Sherva; Zhi-Yi Chen; Hong-Yuan Luo; Benjamin F Chu; Shau Yin Ha; Chi Kong Li; Anselm C W Lee; Rever C H Li; Chi Keung Li; Hui Leung Yuen; Jason C C So; Edmond S K Ma; Li Chong Chan; Vivian Chan; Paola Sebastiani; Lindsay A Farrer; Clinton T Baldwin; Martin H Steinberg; David H K Chui
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

5.  The genetics of hemoglobin A2 regulation in sickle cell anemia.

Authors:  Paula J Griffin; Paola Sebastiani; Heather Edward; Clinton T Baldwin; Mark T Gladwin; Victor R Gordeuk; David H K Chui; Martin H Steinberg
Journal:  Am J Hematol       Date:  2014-08-04       Impact factor: 10.047

6.  Sickle cell disease in the era of precision medicine: looking to the future.

Authors:  Martin H Steinberg; Sara Kumar; George J Murphy; Kim Vanuytsel
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-11-07

7.  Genetic modifiers of Hb E/beta0 thalassemia identified by a two-stage genome-wide association study.

Authors:  Richard Sherva; Orapan Sripichai; Kenneth Abel; Qianli Ma; Johanna Whitacre; Vach Angkachatchai; Wattanan Makarasara; Pranee Winichagoon; Saovaros Svasti; Suthat Fucharoen; Andreas Braun; Lindsay A Farrer
Journal:  BMC Med Genet       Date:  2010-03-30       Impact factor: 2.103

8.  BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.

Authors:  Amanda E Sedgewick; Nadia Timofeev; Paola Sebastiani; Jason C C So; Edmond S K Ma; Li Chong Chan; Goonnapa Fucharoen; Supan Fucharoen; Cynara G Barbosa; Badri N Vardarajan; Lindsay A Farrer; Clinton T Baldwin; Martin H Steinberg; David H K Chui
Journal:  Blood Cells Mol Dis       Date:  2008-08-08       Impact factor: 3.039

9.  A T-to-G transversion at nucleotide -567 upstream of HBG2 in a GATA-1 binding motif is associated with elevated hemoglobin F.

Authors:  Zhiyi Chen; Hong-Yuan Luo; Raveen K Basran; Tien-Huei Hsu; Daniel W H Mang; Lalana Nuntakarn; Cathy G Rosenfield; George P Patrinos; Ross C Hardison; Martin H Steinberg; David H K Chui
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

10.  What influences Hb fetal production in adulthood?

Authors:  Gisele Cristine de Souza Carrocini; Paula Juliana Antoniazzo Zamaro; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.